APA (7th ed.) Citation

Promsorn, P., Yamaguchi, T., Kosaka, H., Aoi, K., Yoshida, K., Matsushima, H., . . . Naganuma, M. (2024). Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib. Molecular & Clinical Oncology, 21(3), N.PAG. https://doi.org/10.3892/mco.2024.2761

Chicago Style (17th ed.) Citation

Promsorn, Panuwat, et al. "Efficacy of Lenvatinib and Transarterial Chemoembolization Combination Therapy in Patients with Hepatocellular Carcinoma Administered an Insufficient Dose of Early Lenvatinib." Molecular & Clinical Oncology 21, no. 3 (2024): N.PAG. https://doi.org/10.3892/mco.2024.2761.

MLA (9th ed.) Citation

Promsorn, Panuwat, et al. "Efficacy of Lenvatinib and Transarterial Chemoembolization Combination Therapy in Patients with Hepatocellular Carcinoma Administered an Insufficient Dose of Early Lenvatinib." Molecular & Clinical Oncology, vol. 21, no. 3, 2024, p. N.PAG, https://doi.org/10.3892/mco.2024.2761.